Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia

Clinical trial NCT04374565 · COMPLETED

Trial details

NCT number: NCT04374565
Sponsor: University of Virginia
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Corona Virus Infection SARS-CoV 2 SARS Pneumonia Pneumonia

Start date: 2020-05-05
Primary completion: 2021-03-05
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.